MORE VIDEOS
Explore more

Latest videos

An Interprofessional Approach to HPV and Oropharyngeal Cancer Prevention Education
An Interprofessional Approach to HPV and Oropharyngeal Cancer Prevention Education administrator 1 Views • 2 years ago

The Massachusetts Oral HPV Prevention Taskforce was created to build connections between medical and dental professionals to increase HPV vaccination rates, decrease HPV-related cancer, and educate both providers and patients on oropharyngeal cancers. In this webinar, members of the taskforce educate the dental community with relevant, medically sound information to empower dental professionals to help their patients make informed decisions about oral health and cancer prevention.

Comments on this video are allowed in accordance with our comment policy:
http://www.cdc.gov/SocialMedia..../Tools/CommentPolicy

This video can also be viewed at
https://www.cdc.gov/vaccines/v....ideos/low-res/Pretee

Oropharyngeal Cancer: Understanding Head and Neck Cancer 🎗️🩺
Oropharyngeal Cancer: Understanding Head and Neck Cancer 🎗️🩺 administrator 0 Views • 2 years ago

This video provides an overview of oropharyngeal cancer, a type of head and neck cancer. Viewers will learn about the causes and symptoms of this type of cancer, as well as ways to reduce their risk. #shorts #medicalshorts #cancer #healthcare

Images and videos from freepik.com
Speech Synthesis by Eleven Labs
Treatments for HPV-Related Oropharyngeal Cancer: Proton Therapy (Radiation) and Chemotherapy
Treatments for HPV-Related Oropharyngeal Cancer: Proton Therapy (Radiation) and Chemotherapy administrator 3 Views • 2 years ago

HPVANDME.ORG
Education. Prevention. Support.
Learn and share.
© 2018 HPVANDME, INC. If you like our videos, please subscribe to our YouTube channel.
We need 1000 subscribers for HPVANDME, a nonprofit 501(c)(3) organization, to get paid for the YouTube ads that you see on our videos. Until then, only YouTube gets paid for these ads.
Thank you for your support.
All rights reserved. This video may not be embedded without permission. Any reproduction or illegal distribution of the content in any form will result in immediate action against the person concerned.
CDC Webinar - Perspectives on Oropharyngeal Cancer
CDC Webinar - Perspectives on Oropharyngeal Cancer administrator 3 Views • 2 years ago

Every year, over 33,000 men and women are diagnosed with a cancer caused by HPV. While cervical cancer is the most well-known cancer that is caused by HPV, there are five other types of cancers that can develop from HPV. Oropharyngeal cancer has recently surpassed cervical cancer as the most common cancer caused by HPV, accounting for nearly 13,000 cases every year in the United States.

Compared to HPV and cervical cancer, awareness of the link between HPV and oropharyngeal cancer is still low, which presents an important opportunity for more education. During this archived webinar, two experts explain the burden of oropharyngeal cancer, current trends in the epidemiology of oropharyngeal cancer, a clinical picture of the disease, and the importance of vaccination to prevent HPV infections. They also address common questions related to HPV and oropharyngeal cancer.

Dr. Amber D’Souza, Associate Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, and Dr. Carole Fakhry, Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, have co-authored several papers about commonly asked questions from patients about HPV-related oropharyngeal cancers, as well as the psychosocial experiences of HPV-related oropharyngeal cancer survivors both during and after treatment.

Finally, the archived webinar helps listeners learn about oropharyngeal cancer through the eyes of a survivor. Jason Mendelsohn is an HPV oropharyngeal cancer survivor who actively shares the story of his illness and recovery as a means to educate the public about HPV and its link to oropharyngeal cancer.

This webinar was originally hosted by the Public Health Foundation on February 13, 2019. For more information about this webinar, please contact Kathleen Amos at kamos@phf.org.
Oral and Oropharyngeal Cancer
Oral and Oropharyngeal Cancer administrator 0 Views • 2 years ago

Oropharyngeal Cancer - MedNet21
Oropharyngeal Cancer - MedNet21 administrator 1 Views • 2 years ago

This video segment serves as a short introduction and educational lesson for our MedNet21 webcast on Oropharyngeal Cancer. The CME webcast can be viewed in its entirety at https://ccme.osu.edu/WebCastSearch.aspx. Enjoy this on-line education.

Oropharyngeal Cancer Staging in 5 minutes - REVISED
Oropharyngeal Cancer Staging in 5 minutes - REVISED administrator 2 Views • 2 years ago

In this video, Dr. Katie Bailey describes the anatomic subsites of the oropharynx and reviews how tumors are staged through four quick example cases.

N.B. The initial version of this video had a few small errors in the staging, so we have corrected them.

0:00 Review of oropharynx anatomy. The oropharynx includes the tonsils (both lingual and palatine), the squamous mucosa of the pharynx, the uvula, and the vallecula. oral cavity includes the lips, teeth, hard and soft palate, gingiva, retromolar trigone, the buccal mucosa, and anterior 2/3 of the tongue. Masticator space. Contains the muscles of mastication, the mandible, branches of the trigeminal nerve, lymph nodes, and minor salivary glands.

0:41 Oropharyngeal cancer staging. Tumor (T) staging is based on the size of the tumor or invasion through adjacent structures. Nodal (N) staging is based on the number, location, and size of nodes, and metastasis (M) staging is based on the presence or absence of distant sites of disease. 1:12 Example case 1. There is a 2.4 cm mass of the right palatine tonsil. There is level 2 and 3 adenopathy. The lymphadenopathy compresses the jugular vein and displaces the adjacent sternocleidomastoid. The size of the tumor makes this a T2 lesion, and the unilateral adenopathy less than 6 cm with multiple nodes makes it N2b. Because metastases can’t be evaluated with this information, it is given an ‘X’ for M staging right now.

1:57 Example case 2. There is a 3.2 cm mass in the tongue base and extending into the vallecula. There is no extension into the adjacent structures or fat. There is a single left sided level 2 lymph node that is somewhat prominent but isn’t definitely abnormal. That makes this a T2N0Mx tumor. If a PET or biopsy later shows that the node is positive, the staging can be changed.

2:42 Example case 3. There is a subtle mass of the right lateral wall of the oropharynx involving the tonsillar pillar and tongue base. This one is quite hard to see. There are cystic necrotic lymph nodes on the right, but none greater than 6 cm. A PET/CT showed no distant metastatic disease. That makes this a T1N2bM0 tumor.

3:51 Example case 4. This patient presented with cervical lymphadenopathy on the left but had no clear primary tumor in the oropharynx. There was no mass of the tongue base or elsewhere. The patient had a lung node suspicious for metastatic disease. A PET/CT showed that there was a primary in the soft palate. The mass was detected only by PET/CT. The final staging for this cancer is T1N2bM1. Thanks for checking out this quick video on oropharyngeal cancer staging.

Be sure to tune back in for additional videos on staging of the other head and neck subsites.

Check out this video and additional content on http://www.learnneuroradiology.com

Oral Cancer: Prevention and treatment options from a medical oncologist | Stanford
Oral Cancer: Prevention and treatment options from a medical oncologist | Stanford administrator 0 Views • 2 years ago

Over 50,000 Americans will be diagnosed with cancer of the head and neck in 2021, but we now have tools to prevent these cancers for future generations. Watch as Dr. Lidia Schapira explains risk factors, steps you can take to protect yourself, and available treatment options.

0:00 Introduction
0:43 What is oral cancer? How does it develop?
1:37 What are risk factors for oral and oropharyngeal cancer?
3:41 How is oral cancer diagnosed and treated?

Dr. Schapira is a medical oncologist and a professor of medicine at Stanford University.

The information in this video was accurate as of the upload date, 12/22/2021. For information purposes only. Consult your local medical authority or your healthcare practitioner for advice.

This video is a production of the Stanford Center for Health Education team, in collaboration with Stanford Medicine, Stanford Center for Professional Development, and Stanford Medicine Education Technology Team.

At the Stanford Center for Health Education, we believe that expanding access to engaging education has the power to change behaviors, improve health, and ultimately save lives.

Stanford Center for Health Education
Website: https://healtheducation.stanford.edu/
Twitter: https://twitter.com/Stanford_CHE
Facebook: https://www.facebook.com/Stanf....ordCenterforHealthEd

Digital Medic
YouTube: https://www.youtube.com/digitalmedic
Website: https://digitalmedic.stanford.edu/
Twitter: https://twitter.com/digital__medic
Facebook: https://www.facebook.com/digitalmedic.org/

Oral & Oropharyngeal Cancer Screening for Today’s Population
Oral & Oropharyngeal Cancer Screening for Today’s Population administrator 1 Views • 2 years ago

Will this be the year you save a life? The mounting body of evidence from the last decade has led to a dire need to alert and further educate the health professional network about oral and oropharyngeal cancer. CDHA's revamped 4-module course will provide a solid and current conceptual framework to elevate oral cancer awareness within the dental hygiene community and ultimately save lives using opportunistic oral cancer screening. Visit cdha.ca/oralcancer for details.
HPV (+) oropharyngeal cancer
HPV (+) oropharyngeal cancer administrator 1 Views • 2 years ago

The incidence of oropharyngeal cancer caused by human papilloma virus (HPV) is increasing so rapidly that now it surpassed that of cervical cancer of women. In this presentation, I discusses its cause, diagnosis, most updated treatment and prognosis.
Showing 3316 out of 3317